Detalles de la búsqueda
1.
Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.
BMC Med Genet
; 17: 21, 2016 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26969407
2.
MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.
Hum Mol Genet
; 22(18): 3624-40, 2013 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23674521
3.
Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension.
Curr Hypertens Rep
; 13(1): 36-45, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21104344
4.
Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension.
Blood Press
; 20(4): 222-31, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21428728
5.
Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.
Physiol Genomics
; 40(3): 195-207, 2010 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19952279
6.
Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach.
Mamm Genome
; 21(3-4): 195-204, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20204374
7.
Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.
Cell Mol Neurobiol
; 30(8): 1395-400, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21061160
8.
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.
Clin Exp Hypertens
; 31(7): 521-33, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19886850
9.
Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension.
Am J Hypertens
; 18(5 Pt 1): 633-52, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15882546
10.
Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism.
PLoS One
; 9(1): e84132, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24465394
11.
Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs.
J Hypertens
; 31(1): 123-33, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23149563
12.
Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure.
J Hypertens
; 30(10): 1961-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22871890
13.
Integrated computational and experimental analysis of the neuroendocrine transcriptome in genetic hypertension identifies novel control points for the cardiometabolic syndrome.
Circ Cardiovasc Genet
; 5(4): 430-40, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22670052
14.
Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.
Endocrinology
; 151(10): 4820-9, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20668031
15.
Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.
Diabetes Obes Metab
; 8(6): 621-33, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17026486
Resultados
1 -
15
de 15
1
Próxima >
>>